Wolverine Trading’s ClearPoint Neuro CLPT Stock Holding History

Wolverine Trading’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$718K	Buy	+33,300	New	+$392K	﹤0.01%	3273
2025 Q1	–	Sell	-10,500	Closed	-$163K	–	4853
2024 Q4	$163K	Buy	+10,500	New	+$136K	﹤0.01%	4640
2023 Q1	–	Sell	-14,200	Closed	-$120K	–	4309
2022 Q4	$120K	Buy	+14,200	New	+$135K	﹤0.01%	3359
2021 Q3	–	Sell	-15,300	Closed	-$289K	–	6326
2021 Q2	$289K	Buy	+15,300	New	+$296K	﹤0.01%	4467

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BCM

Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Wolverine Trading's CLPT Position: Q3 2025 in Review

Wolverine Trading opened a new position in ClearPoint Neuro (CLPT) in Q3 2025: 14,702 shares worth $317K. The stake represents ﹤0.01% of the portfolio and ranks #4302 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in CLPT as recently as Q2 2021.

Wolverine Trading first reported a position in CLPT in Q2 2021 and has held it in 2 quarters since. The position peaked at $384K in Q2 2021. 107 funds tracked by Wall St. Rank hold CLPT as of Q3 2025.

Wolverine Trading held 14,702 shares of ClearPoint Neuro worth $317K as of Q3 2025.
ClearPoint Neuro was a new Wolverine Trading position in Q3 2025.
ClearPoint Neuro made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4302 holding.
Wolverine Trading first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 2 quarters since.
Wolverine Trading's ClearPoint Neuro position peaked at $384K in Q2 2021.
107 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.